MCM6 and meningioma: Moreover, high expression of MCM6 was associated with shorter OS in grade II meningioma patients by the Log rank test (p = 0.02) [44] and in all grades of meningioma patients by univariate Cox regression analysis (HR = 1.005, 95%CI 1.002 to 1.008) [45].